片側二門式内視鏡の2030年までの市場予測：製品別、用途別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、世界の片側二門式内視鏡市場は、2024年に9億7,716万米ドルを占め、予測期間中にCAGR 8.0％で成長し、2030年までに15億5,062万米ドルに達すると予想されています。

脊椎手術は、片側二門式内視鏡（UBE）として知られる洗練された低侵襲手術手技の主な用途です。高解像度のカメラと手術器具を体の同じ側にある2つの小さな切開創から挿入し、脊椎疾患を観察・治療します。開腹手術に比べ、UBEは組織損傷が少なく、回復が早く、筋肉の剥離が少ないなど、多くの利点があります。周囲の構造への障害を最小限に抑え、脊椎への正確な直接アクセスを可能にするこの技術は、患者に従来の技術よりも低侵襲で効率的な選択肢を提供するため、脊椎固定術、椎間板切除術、除圧術などの処置で人気が高まっています。

米国国立衛生研究所（NIH）によると、片側両舷内視鏡などの技術を含む低侵襲脊椎手術は、従来の開腹脊椎手術と比較して、回復時間を最大50％短縮し、術後疼痛を30～40％軽減し、入院期間を20～30％短縮することが示されています。

高まる外来治療のニーズ

外来手術は、世界中のヘルスケア・システムがコスト削減に重点を置くようになった結果、ますます一般的になってきています。このモデルはUBEにとって理想的です。なぜなら、その低侵襲技術は入院期間の短縮と回復時間の短縮をもたらし、患者はより早く通常の活動を再開することができるからです。さらに、UBE手術がいかに効率的で費用対効果に優れているかを理解しているため、UBE手術を保険適用することでこの動向を支持する保険会社も増えています。ヘルスケア・プロバイダーが手術費用を削減し、入院施設にかかる負担を軽減しようとしていることから、外来手術におけるUBEの役割は、今後ますます大きくなっていくと予想されます。

高額な初期設備費用

必要な技術や機器の高額な費用は、UBEを広く使用する上での主な障害の一つです。UBE処置に必要な内視鏡ツール、カメラ、および高度な画像システムの購入と維持にかかる費用は高額です。さらに、これらのシステムは病院や診療所から多額の投資を必要とするため、特に低・中所得の地域では法外な負担となる可能性があります。回復時間の短縮や入院期間の短縮に関連する長期的なコスト削減の可能性があるにもかかわらず、このような高額な初期費用が、一部のヘルスケアプロバイダーがUBEの導入を妨げる可能性があります。

技術開発とロボット工学の統合

UBEとロボット支援技術の組み合わせは、手術のコントロールと精度を向上させる大きなチャンスを提供します。ロボットシステムとUBEを組み合わせることで、低侵襲手技中の外科医の精度が向上し、患者の転帰がさらに改善される可能性があります。UBEはまた、AIや機械学習の応用により、手術ナビゲーションや手術結果の向上にも役立つ可能性があります。さらに、UBEは、こうした技術的進歩の結果、複雑な手術に選択される方法になる可能性があり、専門医療施設での拡大を推進すると思われます。

従来の手術手技との競合

UBEの利用が増加しているにもかかわらず、従来の開腹手術やその他の低侵襲手術は依然として頻繁に行われています。何十年にもわたる臨床データによって安全性と有効性が証明されているため、多くの外科医は、これらの試行錯誤を重ねた術式の方が安心できると考えています。さらに、ヘルスケアプロバイダーや病院はUBEのような新しい技術への投資に消極的です。UBEの市場は、このような従来技術への根強い嗜好の結果、深刻な障害に直面する可能性があり、特定の地域や専門分野での採用が阻害される可能性があります。

COVID-19の影響：

片側二門式内視鏡検査市場は、COVID-19の大流行によって大きな影響を受け、導入と成長が鈍化しました。COVID-19関連の医療ニーズを優先し、病院内での感染リスクを低下させるため、パンデミックの初期段階ではUBEを含む選択手術が延期または中止されました。さらに、UBE機器とトレーニングの利用は、世界サプライチェーンの混乱とパンデミック管理へのヘルスケア資源の再配分によって妨げられました。しかし、低侵襲手術におけるUBEの可能性は、ヘルスケアシステムが調整され、特に手術後の回復時間を短縮し、患者の転帰を向上させようとする市場で、選択的手術が再開されるにつれて再び注目を集めました。

予測期間中は再利用型セグメントが最大になる見込み

片側両側内視鏡市場は、再利用可能セグメントによって支配されると予測されます。効率的な滅菌・消毒手順による回収率の高さもあり、ヘルスケアプロバイダーは再利用可能製品を広く採用しており、これが再利用可能製品の優位性につながっています。再利用可能な器具を感染のリスクに応じて分類することで、有効性と安全性を向上させるカスタマイズされた消毒技術が可能になります。さらに、低侵襲手術が普及するにつれて、再使用型セグメントが引き続き市場を牽引すると予想されるが、感染管理に対する懸念の高まりと、シングルユース製品のメンテナンスの必要性の低さから、シングルユース・セグメントが急成長すると予想されます。

外来手術センターセグメントは予測期間中に最も高いCAGRが見込まれる

片側二門式内視鏡市場では、外来手術センター（ASC）セグメントが最も高いCAGRで成長すると予測されています。低侵襲性外科手術に対する需要の高まりに対応する、専門家が所有・運営するASCの増加がこの拡大の主な要因です。ASCには、コスト削減や即日手術の容易さなど、患者やヘルスケア専門家にとって魅力的なメリットが数多くあります。さらに、好意的な診療報酬慣行や、入院期間を短縮する処置に対する要望の高まりも、外来医療への移行を後押しする要因となっています。

最もシェアの高い地域：

片側2ポータル内視鏡市場は北米地域が支配的と予想されます。非伝染性疾患の罹患率の高さ、高度なヘルスケアシステム、低侵襲な外科手術を必要とする高齢者人口の増加などが、この優位性の主な要因となっています。有利な償還政策と最先端の手術手技に対する嗜好の高まりにより、特に米国はこの市場の主要プレーヤーとなっています。さらに、北米は大手市場プレイヤーの存在と継続的な技術進歩により、片側二重ポータル内視鏡のイノベーションとアプリケーションの重要な拠点となっており、これらも同地域の成長に大きく寄与しています。

CAGRが最も高い地域：

片側二重内視鏡市場は、アジア太平洋地域で最も高いCAGRで成長すると予測されています。ヘルスケアインフラの急速な改善、市場参入企業の投資の増加、イノベーションと新技術の導入を促進する緩やかな規制の枠組みなどが、この成長を促進する要因の一部です。中国やインドのような国々は、医療専門知識の向上と低侵襲外科手術に対する需要の高まりにより、この勢いを牽引しています。さらに、医療専門家が効果的で効率的な治療法を探しているため、この地域では特に高齢者の間で脊椎障害の発生率が増加していることも市場を牽引しています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• 用途分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の片側二門式内視鏡市場：製品別

• 再利用可能
• 使い捨て

第6章 世界の片側二門式内視鏡市場：用途別

• 減圧
  • 腰椎中心管狭窄症
  • 変性性腰部脊柱管狭窄症
  • 腰部脊椎管狭窄症
• ヘルニア除去
• 脊椎の安定化
• その他の用途

第7章 世界の片側二門式内視鏡市場：エンドユーザー別

• 病院
• 外来手術センター
• 専門クリニック
• その他のエンドユーザー

第8章 世界の片側二門式内視鏡市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイリング

• Stryker Corporation
• Karl Storz
• Conmed Corporation
• Kinetix Lifesciences
• Richard Wolf
• Jiangsu Bonss Medical Technology Co. Ltd.
• Smith & Nephew
• Maxer Endoscopy GmbH
• Endovision Co. Ltd.
• Joimax GmbH

List of Tables

• Table 1 Global Unilateral Biportal Endoscopy Market Outlook, By Region (2022-2030) ($MN)
• Table 2 Global Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
• Table 3 Global Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
• Table 4 Global Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
• Table 5 Global Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
• Table 6 Global Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
• Table 7 Global Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
• Table 8 Global Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
• Table 9 Global Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
• Table 10 Global Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
• Table 11 Global Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
• Table 12 Global Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 13 Global Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
• Table 14 Global Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 15 Global Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
• Table 16 Global Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 17 Global Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 18 North America Unilateral Biportal Endoscopy Market Outlook, By Country (2022-2030) ($MN)
• Table 19 North America Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
• Table 20 North America Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
• Table 21 North America Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
• Table 22 North America Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
• Table 23 North America Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
• Table 24 North America Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
• Table 25 North America Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
• Table 26 North America Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
• Table 27 North America Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
• Table 28 North America Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
• Table 29 North America Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 30 North America Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
• Table 31 North America Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 32 North America Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
• Table 33 North America Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 34 North America Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 35 Europe Unilateral Biportal Endoscopy Market Outlook, By Country (2022-2030) ($MN)
• Table 36 Europe Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
• Table 37 Europe Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
• Table 38 Europe Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
• Table 39 Europe Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
• Table 40 Europe Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
• Table 41 Europe Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
• Table 42 Europe Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
• Table 43 Europe Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
• Table 44 Europe Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
• Table 45 Europe Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
• Table 46 Europe Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 47 Europe Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
• Table 48 Europe Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 49 Europe Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
• Table 50 Europe Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 51 Europe Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 52 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Country (2022-2030) ($MN)
• Table 53 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
• Table 54 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
• Table 55 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
• Table 56 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
• Table 57 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
• Table 58 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
• Table 59 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
• Table 60 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
• Table 61 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
• Table 62 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
• Table 63 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 64 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
• Table 65 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 66 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
• Table 67 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 68 Asia Pacific Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 69 South America Unilateral Biportal Endoscopy Market Outlook, By Country (2022-2030) ($MN)
• Table 70 South America Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
• Table 71 South America Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
• Table 72 South America Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
• Table 73 South America Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
• Table 74 South America Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
• Table 75 South America Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
• Table 76 South America Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
• Table 77 South America Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
• Table 78 South America Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
• Table 79 South America Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
• Table 80 South America Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 81 South America Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
• Table 82 South America Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 83 South America Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
• Table 84 South America Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 85 South America Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)
• Table 86 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Country (2022-2030) ($MN)
• Table 87 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Product (2022-2030) ($MN)
• Table 88 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Reusable (2022-2030) ($MN)
• Table 89 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Single-use (2022-2030) ($MN)
• Table 90 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Application (2022-2030) ($MN)
• Table 91 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Decompression (2022-2030) ($MN)
• Table 92 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Lumbar Central Canal Stenosis (2022-2030) ($MN)
• Table 93 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Degenerative Lumbar Canal Stenosis (2022-2030) ($MN)
• Table 94 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Lumbar Spinal Stenosis (2022-2030) ($MN)
• Table 95 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Deherniation (2022-2030) ($MN)
• Table 96 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Spinal Stabilization (2022-2030) ($MN)
• Table 97 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 98 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By End User (2022-2030) ($MN)
• Table 99 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Hospitals (2022-2030) ($MN)
• Table 100 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Ambulatory Surgery Centers (2022-2030) ($MN)
• Table 101 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Specialty Clinics (2022-2030) ($MN)
• Table 102 Middle East & Africa Unilateral Biportal Endoscopy Market Outlook, By Other End Users (2022-2030) ($MN)

According to Stratistics MRC, the Global Unilateral Biportal Endoscopy Market is accounted for $977.16 million in 2024 and is expected to reach $1550.62 million by 2030 growing at a CAGR of 8.0% during the forecast period. Spinal surgery is the main application for the sophisticated minimally invasive surgical technique known as unilateral biportal endoscopy (UBE). A high-definition camera and surgical tools are inserted through two tiny incisions on the same side of the body in order to view and treat spinal disorders. Compared to open surgery, UBE has a number of benefits, including less tissue damage, quicker recovery, and less muscle dissection. With the least amount of disturbance to the surrounding structures, the technique enables precise, direct access to the spine, it has grown in popularity for procedures like spinal fusion, discectomy, and decompression because it offers patients a less invasive and more efficient option than traditional techniques.

According to the National Institutes of Health (NIH), minimally invasive spine surgery, including techniques like unilateral biportal endoscopy, has been shown to reduce recovery times by up to 50%, minimize postoperative pain by 30-40%, and decrease hospital stays by 20-30% compared to traditional open spine surgery.

Market Dynamics:

Driver:

Growing Need for Outpatient Treatments

Outpatient surgeries are becoming more and more popular as a result of healthcare systems around the world focusing more on cutting costs. This model is ideal for UBE since its minimally invasive technique results in shorter hospital stays and faster recovery times, enabling patients to resume their regular activities more quickly. Additionally, an increasing number of insurers are supporting this trend by covering UBE procedures because they understand how efficient and cost-effective they are. It is anticipated that UBE's role in outpatient surgery will grow as healthcare providers seek to reduce operating expenses and the strain on inpatient facilities.

Restraint:

Expensive initial equipment costs

The high expense of the required technology and equipment is one of the main obstacles to the broad use of UBE. The cost of purchasing and maintaining the endoscopic tools, cameras, and sophisticated imaging systems needed for UBE procedures is high. Furthermore, these systems require large investments from hospitals and clinics, which can be prohibitive, particularly in areas with low and middle incomes. Despite the possible long-term cost savings associated with quicker recovery times and shorter hospital stays, these high upfront costs may prevent some healthcare providers from implementing UBE.

Opportunity:

Technological developments and robotics integration

The combination of UBE and robotic-assisted technologies offers a significant chance to improve surgical control and precision. Combining robotic systems with UBE could further enhance patient outcomes by giving surgeons more accuracy during minimally invasive procedures. UBE may also be useful in enhancing surgical navigation and results through the application of AI and machine learning. Moreover, UBE may become the method of choice for complex surgeries as a result of these technological advancements, which would propel its expansion in specialty medical facilities.

Threat:

Competition from conventional surgical techniques

Traditional open surgeries and other minimally invasive procedures are still frequently employed despite the increasing use of UBE. Many surgeons continue to feel more at ease using these tried-and-true techniques because they have been proven safe and effective by decades of clinical data. Furthermore, healthcare providers and hospitals are reluctant to invest in newer technologies like UBE because they frequently prioritize tried-and-true, affordable treatments. The market for UBE may face serious obstacles as a result of this ingrained preference for conventional techniques, which could impede its adoption in particular areas or specialties.

Covid-19 Impact:

The market for unilateral biportal endoscopy was greatly impacted by the COVID-19 pandemic, which caused a slowdown in adoption and growth. In order to prioritize COVID-19-related healthcare needs and lower the risk of transmission in hospitals, elective surgeries, including those involving UBE, were delayed or cancelled during the early stages of the pandemic. Additionally, the availability of UBE equipment and training was hindered by the disruption of global supply chains and the redirection of healthcare resources towards pandemic management. UBE's potential for minimally invasive surgery, however, attracted renewed attention as healthcare systems adjusted and elective surgeries resumed, especially in markets seeking to shorten recovery times following surgery and enhance patient outcomes.

The Reusable segment is expected to be the largest during the forecast period

The unilateral bilateral endoscopy market is anticipated to be dominated by the reusable segment. Due in large part to their high recoverability rates through efficient sterilization and disinfection procedures, healthcare providers have adopted reusable products widely, which has led to their dominance. The classification of reusable instruments according to the risks of infection enables customized disinfection techniques that improve efficacy and safety. Furthermore, the market is expected to continue to be led by the reusable segment as minimally invasive surgeries gain popularity, but the single-use segment is expected to grow quickly because of growing concerns about infection control and the lower maintenance needs of single-use products.

The Ambulatory Surgery Centers segment is expected to have the highest CAGR during the forecast period

In the unilateral biportal endoscopy market, the ambulatory surgery centers (ASCs) segment is anticipated to grow at the highest CAGR. The rise in professionally owned and operated ASCs, which meet the growing demand for minimally invasive surgical procedures, is the main driver of this expansion. ASCs have a number of benefits that are appealing to patients and healthcare professionals alike, such as cost savings and the ease of same-day surgeries. Moreover, favourable reimbursement practices and a growing desire for procedures that shorten hospital stays are additional factors supporting the move towards outpatient care.

Region with largest share:

The market for unilateral biportal endoscopy is expected to be dominated by the North American region. The high incidence of non-communicable diseases, the sophisticated healthcare system, and the growing geriatric population that demands minimally invasive surgical procedures are all major contributors to this dominance. Due to its advantageous reimbursement policies and growing preference for cutting-edge surgical techniques, the United States in particular is a major player in this market. Additionally, North America is a key hub for unilateral biportal endoscopy innovations and applications due to the presence of major market players and ongoing technological advancements, which also greatly contribute to the region's growth.

Region with highest CAGR:

The unilateral biportal endoscopy market is anticipated to grow at the highest CAGR in the Asia-Pacific region. Rapid improvements in healthcare infrastructure, rising market player investments, and a laxer regulatory framework that promotes innovation and the uptake of new technologies are some of the factors driving this growth. Because of their growing medical expertise and rising demand for minimally invasive surgical procedures, nations like China and India are driving this momentum. Furthermore, the market is driven by the increasing incidence of spinal disorders, especially among the elderly population in this area, as medical professionals look for effective and efficient treatment alternatives.

Key players in the market

Some of the key players in Unilateral Biportal Endoscopy market include Stryker Corporation, Karl Storz, Conmed Corporation, Kinetix Lifesciences, Richard Wolf, Jiangsu Bonss Medical Technology Co. Ltd., Smith & Nephew, Maxer Endoscopy GmbH, Endovision Co. Ltd. and Joimax GmbH.

Key Developments:

In August 2024, Stryker announced a definitive agreement to acquire care.ai, a privately held company specializing in delivering AI-assisted virtual care workflows, smart room technology and ambient intelligence solutions. The acquisition will strengthen Stryker's growing healthcare IT offering and wirelessly connected medical device portfolio.

In June 2024, Karl Storz Endoscopy-America, a subsidiary of medical technology company Karl Storz Se & Co, has agreed to acquire Asensus Surgical. Under the agreement, KARL STORZ will acquire all outstanding shares of Asensus for $0.35 per share in cash.

In February 2024, Smith+Nephew, the global medical technology company, announces an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT(TM) in Australia. A single-use, sterile navigation system with everything provided in a small carton, NAVBIT SPRINT(TM) is designed to suit busy surgeons - and its convenient product format makes it extremely practical and cost efficient for hospitals and day surgery environments.

Products Covered:

• Reusable
• Single-use

Applications Covered:

• Decompression
• Deherniation
• Spinal Stabilization
• Other Applications

End Users Covered:

• Hospitals
• Ambulatory Surgery Centers
• Specialty Clinics
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Unilateral Biportal Endoscopy Market, By Product

• 5.1 Introduction
• 5.2 Reusable
• 5.3 Single-use

6 Global Unilateral Biportal Endoscopy Market, By Application

• 6.1 Introduction
• 6.2 Decompression
  • 6.2.1 Lumbar Central Canal Stenosis
  • 6.2.2 Degenerative Lumbar Canal Stenosis
  • 6.2.3 Lumbar Spinal Stenosis
• 6.3 Deherniation
• 6.4 Spinal Stabilization
• 6.5 Other Applications

7 Global Unilateral Biportal Endoscopy Market, By End User

• 7.1 Introduction
• 7.2 Hospitals
• 7.3 Ambulatory Surgery Centers
• 7.4 Specialty Clinics
• 7.5 Other End Users

8 Global Unilateral Biportal Endoscopy Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Stryker Corporation
• 10.2 Karl Storz
• 10.3 Conmed Corporation
• 10.4 Kinetix Lifesciences
• 10.5 Richard Wolf
• 10.6 Jiangsu Bonss Medical Technology Co. Ltd.
• 10.7 Smith & Nephew
• 10.8 Maxer Endoscopy GmbH
• 10.9 Endovision Co. Ltd.
• 10.10 Joimax GmbH